BioSpace News Archive

Drug Development

Coveted GLP-1 Drugs Show Early Promise in Alzheimer’s Disease

With a recent study yielding positive results, experts say GLP-1 drugs are making headway in treating Alzheimer’s and other neurodegenerative diseases.

August 31, 2023
·
5 min read
·
Heather McKenzie
Business

J&J Earns $13.2B from Kenvue Spinout, Lowers Guidance

Johnson & Johnson on Wednesday reported multi-billion earnings from its Kenvue consumer health spinout, with updated 2023 revenue guidance down from its previously announced range.

August 31, 2023
·
2 min read
·
Tristan Manalac
Policy

Alkermes Settles Patent Lawsuit with Teva Over Generic Vivitrol

The settlement, announced Wednesday, ends a three-year legal battle allowing Teva Pharmaceuticals to make a generic version of Alkermes’ alcohol and opioid dependence drug Vivitrol.

August 31, 2023
·
2 min read
·
Connor Lynch
FDA

FDA Approves Generics of Takeda’s ADHD, Binge Eating Drug Vyvanse

Amid a supply shortage of the attention-deficit/hyperactivity disorder and binge-eating disorder medication, the regulator has cleared a slew of generic drugs of Takeda’s Vyvanse pill.

August 31, 2023
·
2 min read
·
Tristan Manalac
Business

Sage Cuts Staff by 40% After FDA’s MDD Rejection

Following the FDA’s recent rejection of zuranolone in major depressive disorder, Sage Therapeutics has launched a strategic reorganization initiative including a 40% reduction in headcount.

August 31, 2023
·
2 min read
·
Tristan Manalac
Business

Burning Rock Reports Second Quarter 2023 Financial Results

Burning Rock Biotech Limited, a company focused on the application of next generation sequencing technology in the field of precision oncology, reported financial results for the three months ended June 30, 2023.

August 31, 2023
·
19 min read
Business

CANbridge Announces Interim Financial Results and Corporate Updates for the Six Months Ended June 30, 2023

CANbridge Pharmaceuticals, Inc. announced its financial results for the six months ended June 30, 2023 plus corporate updates.

August 31, 2023
·
8 min read
Business

Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a drug discovery agreement with Ono Pharmaceutical Co., Ltd. to discover and develop novel antibodies for the treatment of autoimmune diseases.

August 31, 2023
·
7 min read
Genetown

Sage Therapeutics Implements Strategic Reorganization to Support Plans for ZURZUVAE™ Commercial Launch and Pipeline Advancement

Sage Therapeutics, Inc., announced plans to reorganize its business operations and pipeline priorities to support goals for long-term business growth, including the planned commercial launch of ZURZUVAE for women with postpartum depression in late 2023.

August 31, 2023
·
9 min read
Business

Press Release: Sanofi announces changes to its Executive Committee

Houman, Madeleine and Emmanuel will report to Sanofi’s CEO, Paul Hudson, and will be based in Paris, France.

August 31, 2023
·
11 min read